How comparing works here
How do I compare two companies?
Type the tickers into the box above — up to five at once. Every row is read from the companies' own annual filings, so a comparison shows the same measure computed the same way for each of them rather than whatever each company chose to highlight.
Can I compare an ETF with a stock?
Yes, and the table changes to suit. Two funds are compared on cost, income, spread and record, because revenue growth and debt mean nothing for a fund. A fund against a company shows only what both of them have.
Side by side
Compare
Put up to 4 companies, funds, commodities or coins next to each other — health, valuation, growth and performance.
Every row is computed the same way for every column, from each company's own annual filing, so a comparison is not a collection of whichever figures each of them chose to put in a press release. Funds are compared on what a fund is actually judged on: cost, income, spread and record.
Relative performance
Rebased so every symbol starts at 0%
Loading price history…
Side by side
Latest annual figures from each company's filings
| Metric | CICigna Group | CVSCVS HEALTH Corp | DGXQUEST DIAGNOSTICS INC | LHLABCORP HOLDINGS INC. | Median of the restexcluding CI |
|---|---|---|---|---|---|
| Type | Company | Company | Company | Company | |
| Price | $304.37▼ 2.23 (0.73%) | $94.48▲ 1.03 (1.10%) | $243.28▲ 4.35 (1.82%) | $329.93▲ 6.18 (1.91%) | |
| Health scoreComposite of profitability, growth, debt and accounting quality. | 6.0/10 | 4.7/10 | 8.0/10 | 7.0/10 | 7.0/10 |
| Market value | $80.19B | $120.08B | $27.00B | $27.12B | |
| Revenue | $274.90B | $402.07B | $11.04B | $13.95B | |
| Profit | $5.96B | $1.77B | $992.0M | $876.5M | |
| Revenue growthChange in sales versus the prior year. | 11.2% | 7.8% | 11.8% | 7.2% | 7.8% |
| Gross marginShare of sales left after the direct cost of producing them. | 21.8% | 45.0% | 33.2% | 28.8% | 33.2% |
| Operating marginShare of sales left after running the business, before interest and tax. | 3.3% | 1.2% | 14.1% | 9.9% | 9.9% |
| Profit marginProfit kept from each dollar of sales. | 2.2% | 0.4% | 9.0% | 6.3% | 6.3% |
| Free cash flow marginCash left after capital spending, as a share of sales. | — | 1.9% | 12.3% | 8.6% | 8.6% |
| Return on equityProfit against the owners' stake in the company. | 14.3% | 2.4% | 13.8% | 10.2% | 10.2% |
| Return on invested capital (approx.)Operating profit after tax against equity plus debt, less cash. Cash here excludes short-term investments, so this runs low for cash-rich companies. | 10.8% | 3.0% | 9.4% | 8.0% | 8.0% |
| P/E ratioPrice paid per dollar of annual profit. | 13.46x | 67.92x | 27.22x | 30.94x | 30.94x |
| EV / EBITDA (approx.)Market value plus debt less cash, against operating profit before depreciation. Cash excludes short-term investments, so this runs high for cash-rich companies. | 8.68x | 18.58x | 15.17x | 15.57x | 15.57x |
| Price to book | 1.92x | 1.60x | 3.77x | 3.15x | 3.15x |
| Debt to equityTotal liabilities compared with owners' stake. | 2.78x | 2.37x | 1.26x | 1.13x | 1.26x |
| Piotroski F-ScoreNine checks of financial strength. Higher is stronger. | 7/9 | 8/9 | 8/9 | 8/9 | 8.0 |
| Bankruptcy riskAltman Z-Score zone. | n/a for banks | distress | safe | safe |
How CI compares with the others
- CI's operating margin of 3.3% is lower than the median of the other companies selected (9.9%).
- Its revenue grew faster than the median of the other companies selected: 11.2% against 7.8%.
- It trades at a lower P/E than the median of the other companies selected: 13.5x against 30.9x.
- Its liabilities are higher relative to equity than the median of the other companies selected: 2.8x against 1.3x.
Measured against the other companies entered, from each one's latest annual filing. A difference describes the companies; it does not rank them.